Creative Planning
ZYME icon

Creative Planning’s Zymeworks ZYME Stock Holding History

Creative Planning’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$777K Sell
29,731
-2,663
-8% -$67.7K ﹤0.01% 2859
2026
Q1 		$811K Buy
32,394
+4,101
+14% +$97K ﹤0.01% 2631
2025
Q4 		$745K Buy
28,293
+979
+4% +$21.4K ﹤0.01% 2511
2025
Q3 		$467K Buy
27,314
+1,925
+8% +$27.6K ﹤0.01% 2784
2025
Q2 		$319K Buy
25,389
+13,567
+115% +$162K ﹤0.01% 2847
2025
Q1 		$141K Buy
11,822
+11,765
+20,640% +$160K ﹤0.01% 3178
2024
Q4 		$834 Buy
+57
New +$797 ﹤0.01% 3551

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Creative Planning's ZYME Position: Q2 2026 in Review

Creative Planning reduced its Zymeworks (ZYME) stake by 8.2% in Q2 2026, selling an estimated $67.7K and leaving 29,731 shares worth $777K. The position accounts for ﹤0.01% of the portfolio, ranked #2859.

Creative Planning first reported a position in ZYME in Q4 2024 and has held it in 7 quarters since. The position peaked at $811K in Q1 2026. 203 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Creative Planning held 29,731 shares of Zymeworks worth $777K as of Q2 2026.
  • Creative Planning sold 2,663 Zymeworks shares in Q2 2026, an estimated $67.7K.
  • Zymeworks made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #2859 holding.
  • Creative Planning first reported a position in Zymeworks in Q4 2024 and has held it in 7 quarters since.
  • Creative Planning's Zymeworks position peaked at $811K in Q1 2026.
  • 203 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.